1. Home
  2. CMPS vs LCNB Comparison

CMPS vs LCNB Comparison

Compare CMPS & LCNB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CMPS
  • LCNB
  • Stock Information
  • Founded
  • CMPS 2020
  • LCNB 1877
  • Country
  • CMPS United Kingdom
  • LCNB United States
  • Employees
  • CMPS N/A
  • LCNB N/A
  • Industry
  • CMPS Biotechnology: Pharmaceutical Preparations
  • LCNB Major Banks
  • Sector
  • CMPS Health Care
  • LCNB Finance
  • Exchange
  • CMPS Nasdaq
  • LCNB Nasdaq
  • Market Cap
  • CMPS 246.5M
  • LCNB 197.9M
  • IPO Year
  • CMPS 2020
  • LCNB N/A
  • Fundamental
  • Price
  • CMPS $3.91
  • LCNB $15.22
  • Analyst Decision
  • CMPS Strong Buy
  • LCNB
  • Analyst Count
  • CMPS 6
  • LCNB 0
  • Target Price
  • CMPS $20.20
  • LCNB N/A
  • AVG Volume (30 Days)
  • CMPS 862.1K
  • LCNB 18.7K
  • Earning Date
  • CMPS 05-08-2025
  • LCNB 04-22-2025
  • Dividend Yield
  • CMPS N/A
  • LCNB 5.83%
  • EPS Growth
  • CMPS N/A
  • LCNB 31.98
  • EPS
  • CMPS N/A
  • LCNB 1.14
  • Revenue
  • CMPS N/A
  • LCNB $82,862,000.00
  • Revenue This Year
  • CMPS N/A
  • LCNB N/A
  • Revenue Next Year
  • CMPS N/A
  • LCNB $7.44
  • P/E Ratio
  • CMPS N/A
  • LCNB $13.19
  • Revenue Growth
  • CMPS N/A
  • LCNB 18.71
  • 52 Week Low
  • CMPS $2.49
  • LCNB $12.42
  • 52 Week High
  • CMPS $9.63
  • LCNB $17.92
  • Technical
  • Relative Strength Index (RSI)
  • CMPS 58.19
  • LCNB 56.31
  • Support Level
  • CMPS $3.62
  • LCNB $14.46
  • Resistance Level
  • CMPS $4.00
  • LCNB $14.90
  • Average True Range (ATR)
  • CMPS 0.28
  • LCNB 0.45
  • MACD
  • CMPS -0.00
  • LCNB 0.05
  • Stochastic Oscillator
  • CMPS 48.23
  • LCNB 80.51

About CMPS COMPASS Pathways Plc American Depository Shares

Compass Pathways PLC is a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health. The company is motivated by the need to find ways to help and empower people suffering with mental health challenges who are not helped by existing therapies and are pioneering the development of a new model of psilocybin therapy, in which psilocybin is administered in conjunction with psychological support. Its focus is on treatment-resistant depression, or TRD, a subset of depressive disorder, or MDD, comprising patients who are inadequately served by the treatment paradigm. It has developed a proprietary, high-purity polymorphic crystalline formulation of psilocybin, COMP360.

About LCNB LCNB Corporation

LCNB Corp operates within the financial sector in the United States. As the holding company of the National Bank, it conducts the business of providing commercial and personal banking services. Its suite of banking products includes commercial and industrial loans, consumer loans, safe deposit boxes, night depositories, cashier's checks, utility bill collections and notary public service. Besides, it provides the avenue of United States Treasury notes, the United States agency notes, certificates of deposit, and equity securities.

Share on Social Networks: